Ash MacLauchlan

Medical student, University of Oxford

Ash is a fifth-year medical student at the University of Oxford, with a particular interest in Type 1 diabetes, early detection, and the future of diabetes care. Having tested positive for two islet autoantibodies at the age of 11, Ash was diagnosed with Type 1 diabetes in 2020, five years after initial screening. During his medical studies, Ash has explored the respective roles of immunotherapy and automated insulin delivery in shaping the future of Type 1 diabetes management. As a member of the UK Islet Autoantibody Registry’s Patient and Public Involvement (PPI) group, he enjoys contributing his lived experience to discussions surrounding screening, follow-up, and prevention research.